Viatris Stock Is Still Worth Buying [Seeking Alpha]
Viatris Inc. (VTRS)
Company Research
Source: Seeking Alpha
Although net sales declined (as did EBITDA and net profit) in 2023, we saw an improvement in the gross profit margin and a continuation of the deleveraging trend. The company has two new drugs ready for commercialization, Selatogrel and Cenerimod, which have significant growth potential, in my view. I like the way the company has developed recently. Although the 55% growth potential I talked about earlier has now fallen to 30%, the stock is still worth buying, in my view. I do much more than just articles at Beyond the Wall Investing: Members get access to model portfolios, regular updates, a chat room, and more. Learn More » Intro & Thesis I initiated coverage on Viatris Inc NASDAQ: VTRS ) in October 2021, and then updated my bullish thesis a few months ago , stating that the stock looked dirt cheap. The VTRS stock rose significantly by 26.7% since my last update, outperforming the S&P 500 Index ( SPX SP500 Due to the abundance of new data that has emerged since November
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris to Participate in the BofA Securities 2024 Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in the BofA Securities 2024 Health Care ConferencePR Newswire
- NeurologyLive® and CMSC Announce the 3rd Annual Class of Inductees [Yahoo! Finance]Yahoo! Finance
- Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health [Yahoo! Finance]Yahoo! Finance
- Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthPR Newswire
VTRS
Earnings
- 2/28/24 - Miss
VTRS
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/19/24 - Form 4
- 4/19/24 - Form 3
- VTRS's page on the SEC website